Clinical trial
Zenith TX2® TAA Endovascular Graft Post-approval Study
NCT00813358 is registered in ClinicalTrials.gov with Cook Research Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zenith TX2® TAA Endovascular Graft Post-approval Study
- Lead sponsor
- Cook Research Incorporated
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 10, 2009
- Completion date
- March 23, 2020
- Enrollment
- 115 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.